KNSA
USDKiniksa Pharmaceuticals International plc Class A Ordinary Shares
$38.755-0.325 (-0.832%)
即時價格
Healthcare
Drug Manufacturers - Specialty & Generic
英國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$39.080
最高
$39.220
最低
$38.570
交易量
0.35M
公司基本面
市值
2.9B
行業
Drug Manufacturers - Specialty & Generic
國家
United Kingdom
交易統計
平均交易量
0.46M
交易所
NMS
貨幣
USD
52週範圍
最低 $17.82當前 $38.755最高 $42.05
相關新聞
Analyst Upgrades
Goldman Sachs Maintains Buy on Kiniksa Pharmaceuticals, Raises Price Target to $55
Goldman Sachs analyst Paul Choi maintains Kiniksa Pharmaceuticals with a Buy and raises the price target from $45 to $55.
查看更多
GlobeNewswire
Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution
– ARCALYST® (rilonacept) Q3 2025 net product revenue of $180.9 million, representing 61% year-over-year growth –– ARCALYST 2025 expected net product revenue raised to $670 - $675 million –– KPL-387 granted Orphan
查看更多
Analyst Upgrades
Wedbush Maintains Outperform on Kiniksa Pharmaceuticals, Raises Price Target to $44
Wedbush analyst David Nierengarten maintains Kiniksa Pharmaceuticals with a Outperform and raises the price target from $38 to $44.
查看更多
